Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
BioConferenceLive
JIB

High-Performance Calorimeter Enables Superior Materials Analysis and Development

By BiotechDaily International staff writers
Posted on 30 Apr 2013
Image: Shimadzu’s DSC-60 Plus series new differential scanning calorimeter (Photo courtesy of Shimadzu).
Image: Shimadzu’s DSC-60 Plus series new differential scanning calorimeter (Photo courtesy of Shimadzu).
A new, simple-to-operate, differential scanning calorimeter incorporates new technology designed to offer high sensitivity and resolution required for materials characterization in R&D and quality control applications for areas such as pharmaceuticals, polymers, etc.

Shimadzu (Kyoto, Japan) introduces their new thermal analyzer, the DSC-60 Plus series differential scanning calorimeter (DSC), for the analysis and development of high-performance, highly functional materials. In addition to top-class sensitivity and resolution, a new detector and a unique furnace construction achieve a noise level of less than 0.5 μW, providing a stable baseline from ultralow to high temperatures—across the entire measured temperature range (-140–600 °C). It also features a wide dynamic measurement range of ±150 mW (extended three times compared to previous Shimadzu instruments).

The DSC-60 Plus enables diverse and complex calorimetric measurements via simple operations. A cooling chamber with a liquid-nitrogen option permits easy measurements below room temperature (RT) - extremely convenient as it eliminates the need to install special accessories. A sample loading temperature function (SLTF) enables quick sample change during sequential analysis: while running a series of analyses below RT, the furnace temperature must be returned to near RT during sample replacement—the SLTF heats only the region around the sample when the sample is replaced, so that measurement can be rapidly resumed without moisture condensation.

The DSC-60 Plus is also eco-friendly. The newly designed furnace unit reduces energy consumption by over 20%, as measured when heating from RT to 300 °C at a 20 °C/minute heating rate (compared to previous Shimadzu instruments). When making measurements below RT, the liquid-nitrogen consumption savings exceed 30% (compared to previous Shimadzu instruments). The instrument footprint (W: 320 x H: 500 x D: 500 (mm)) has also been minimized.

The DSC-60 Plus series complies with various guidelines and regulations involving analytical laboratories, such as the PIC/S GMP guidelines, and electronic record/electronic signature (ER/ES) regulations and policies, including the US FDA 21 CFR Part11. In addition, it is compatible with various other analytical instruments and connected network systems, helping to ensure overall laboratory compliance.

Related Links:

Shimadzu



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.